© 2020 MJH Life Sciences and Contagion Live. All rights reserved.
© 2020 MJH Life Sciences™ and Contagion Live. All rights reserved.
October 26, 2020
Invasive C glabrata found to be most prevalent strain of Candida in stool of patients with C difficile infection, and likely resistant to caspofungin.
October 22, 2020
October 18, 2020
An antiprotozoal used in veterinary medicine demonstrates potential for repurposing to replace metronidazole to treat Clostridioides difficile.
September 08, 2020
The 2-step algorithm for diagnosing Clostridioides difficile infection is difficult to interpret in patients who have cancer or are immunocompromised.
August 11, 2020
Administration of the investigational oral microbiome therapeutic SER-109 resulted in a statistically significant decrease in the proportion of patients who had C diff recurrence within 8 weeks of administration versus placebo.
June 16, 2020
Expansion of antimicrobial stewardship strategies to include vertical methods represents an opportunity for programs, both new and established, to further optimize antimicrobial use.
May 27, 2020
A dosage of 250 mg twice daily for 10 days was confirmed for the next phase of trials after achieving initial and sustained cure in 100% of patients.
May 06, 2020
An interview with the Rebiotix founder on the microbiota-based therapy and the newest preliminary pivotal phase 3 findings.
April 24, 2020
Before undergoing fecal microbiota transplant, “patients deserve risk mitigation, which can be accomplished with thorough vetting and regulation,” the authors of a new paper wrote.
April 15, 2020
Community-acquired infections—including those associated with outpatient settings—are still problematic, authors say.